BioMarin Pharmaceutical Inc.
GB ˙ LSE ˙ US09061G1013
57,62 $ ↑1,19 (2,11%)
2026-06-05
DEL PRIS
SecurityGB:0HNC / BioMarin Pharmaceutical Inc.
InstitutionCIBC Asset Management Inc
Latest Disclosed Ownership5,927 shares
Latest Disclosed Value $ 334,816
CIBC Asset Management Inc reports 0.44% decrease in ownership of 0HNC / BioMarin Pharmaceutical Inc.

On May 12, 2026 - CIBC Asset Management Inc filed a 13F-HR form disclosing ownership of 5,927 shares of BioMarin Pharmaceutical Inc. (GB:0HNC) valued at $330,134 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 5,953 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of -0.44% during the quarter. The current value of the position is $341,514 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,927 -26 -0.44 335 -5.38 0.0008
2026-02-10 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,953 -2,248 -27.41 354 -20.50 0.0009
2025-10-31 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 8,201 58 0.71 444 -0.67 0.0013
2025-08-14 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 8,143 53 0.66 448 -21.72 0.0014
2025-05-13 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 8,090 433 5.65 572 13.52 0.0019
2025-01-31 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 7,657 926 13.76 503 6.34 0.0016
2024-11-06 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 6,731 359 5.63 473 -9.73 0.0015
2024-08-01 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 6,372 325 5.37 525 -0.76 0.0019
2024-05-09 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 6,047 13 0.22 528 -9.12 0.0018
2024-02-13 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 6,034 -445 -6.87 582 1.40 0.0022
2023-10-30 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 6,479 155 2.45 573 4.56 0.0024
2023-08-14 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 6,324 4 0.06 548 -10.75 0.0021
2023-05-12 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 6,320 311 5.18 615 -1.13 0.0024
2023-02-13 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 6,009 -2,233 -27.09 622 -11.16 0.0026
2022-11-03 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 8,242 22 0.27 699 2.64 0.0031
2022-08-09 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 8,220 -3,569 -30.27 681 -25.08 0.0028
2022-05-06 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 11,789 -28,805 -70.96 909 -74.65 0.0032
2022-02-08 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 40,594 920 2.32 3,586 16.96 0.0131
2021-11-09 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 39,674 6,366 19.11 3,066 10.33 0.0124
2021-08-16 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 33,308 3,476 11.65 2,779 23.35 0.0112
2021-05-14 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 29,832 23,128 344.99 2,253 283.16 0.0096
2021-02-03 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 6,704 -12,222 -64.58 588 -59.17 0.0028
2020-11-05 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 18,926 1,016 5.67 1,440 -34.81 0.0073
2020-07-28 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 17,910 708 4.12 2,209 51.93 0.0130
2020-04-30 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 17,202 -51,100 -74.81 1,454 -74.82 0.0103
2020-02-14 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 68,302 51,687 311.09 5,775 415.63 0.0327
2019-10-30 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 16,615 -406 -2.39 1,120 -23.18 0.0066
2019-08-05 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 17,021 591 3.60 1,458 -0.07 0.0087
2019-05-06 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 16,430 -332 -1.98 1,459 2.24 0.0090
2019-02-12 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 16,762 568 3.51 1,427 -9.11 0.0105
2018-11-02 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 16,194 340 2.14 1,570 5.16 0.0097
2018-08-09 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,854 986 6.63 1,493 23.90 0.0093
2018-04-30 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 14,868 155 1.05 1,205 -8.16 0.0078
2018-02-02 2017-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 14,713 1,357 10.16 1,312 5.55 0.0080
2017-11-06 2017-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 13,356 838 6.69 1,243 9.32 0.0078
2017-07-27 2017-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 12,518 680 5.74 1,137 9.43 0.0079
2017-05-12 2017-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 11,838 43 0.36 1,039 6.35 0.0071
2017-02-08 2016-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 11,795 72 0.61 977 -9.95 0.0070
2016-10-19 2016-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 11,723 56 0.48 1,085 19.49 0.0080
2016-08-02 2016-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 11,667 178 1.55 908 -4.22 0.0068
2016-05-09 2016-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 11,489 280 2.50 948 -19.25 0.0071
2016-02-02 2015-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 11,209 1,190 11.88 1,174 11.28 0.0097
2015-11-03 2015-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 10,019 3,934 64.65 1,055 26.80 0.0084
2015-08-06 2015-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 6,085 203 3.45 832 13.51 0.0058
2015-05-08 2015-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,882 262 4.66 733 44.29 0.0052
2015-02-10 2014-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,620 169 3.10 508 29.26 0.0034
2014-11-05 2014-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,451 -50 -0.91 393 4.80 0.0023
2014-05-09 2014-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,501 5,501 375 0.0022
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.